Viral-inhibiting method
First Claim
Patent Images
1. A method of transcutaneously inhibiting viral phenomenon at a person'"'"'s skin comprising the acts of:
- superimposing an anti-viral signal upon a reversible carrier signal to produce a composite wave having a current less than one milliampere;
externally applying the less than one milliampere composite wave in one direction to flow across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time whereby the composite wave disrupts viral activity in one flow direction;
essentially instantaneously reversing the carrier signal component of the composite wave to oppositely flow and externally apply the less than one milliampere composite wave across the viral-laden region between the spaced electrodes for a second controlled interval of time whereby the composite wave disrupts viral activity in a second flow direction.
2 Assignments
0 Petitions
Accused Products
Abstract
A hand-held viral inhibitor and related methodology which transfer between space exposed electrodes an electric current signal of reversing polarity through the viral-laden tissue are disclosed.
57 Citations
11 Claims
-
1. A method of transcutaneously inhibiting viral phenomenon at a person'"'"'s skin comprising the acts of:
-
superimposing an anti-viral signal upon a reversible carrier signal to produce a composite wave having a current less than one milliampere; externally applying the less than one milliampere composite wave in one direction to flow across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time whereby the composite wave disrupts viral activity in one flow direction; essentially instantaneously reversing the carrier signal component of the composite wave to oppositely flow and externally apply the less than one milliampere composite wave across the viral-laden region between the spaced electrodes for a second controlled interval of time whereby the composite wave disrupts viral activity in a second flow direction. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
Specification